DAPTA

Star0

DB16290InvestigationalSmall molecule

DAPTA: Overview.

Mechanism: Pharmacologically active on C-C chemokine receptor type 5
Curator reviewed
Formula / weight: C₃₅H₅₆N₁₀O₁₅ · 856.888 g/mol (avg)
Also known as: Adaptavir · Peptide t amide, 1(d-ala)
Code names: DAPTA

Resolves to

Compound

UNIIJ208V4ZMP2CAS106362-34-9ChEMBLCHEMBL181276

Structure

InChIKeyAKWRNBWMGFUAMF-ZESMOPTKSA-NSMILES

C[C@@H](O)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O

Targets

P51681CCR5

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with DAPTA, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account